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Long-term  culture  of neonatal  rat  SGN  with  mitotic  inhibition  by  AraC is  possible.
AraC  is  suitable  for  inhibition  of  uncontrolled  proliferation  of non-neuronal  cells.
AraC  inﬂuences  neither  neuronal  survival  nor  neurite  outgrowth  or soma  diameter.
By  AraC-treatment  it  is  possible  to raise  the  neuronal  ratio  in cultured  SGC.
Neurites  remain  partly  free of  non-neuronal  cells  after  AraC-treatment.
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Background:  Sensorineural  deafness  is  mainly  caused  by  damage  to  hair  cells  and  degeneration  of  the
spiral  ganglion  neurons  (SGN).  Cochlear  implants  can  functionally  replace  lost  hair  cells  and  stimulate
the  SGN  electrically.  The  beneﬁt  from  cochlear  implantation  depends  on  the  number  and excitability  of
these  neurons.  To  identify  potential  therapies  for SGN  protection,  in  vitro  tests  are  carried  out  on  spiral
ganglion cells  (SGC).
New method:  A glial  cell-reduced  and  neuron-enhanced  culture  of neonatal  rat  SGC  under  mitotic  inhibi-
tion  (cytarabine  (AraC))  for  up  to seven  days  is  presented.  Serum  containing  and neurotrophin-enriched
cultures  with  and  without  AraC-addition  were  analyzed  after  4 and  7 days.
Results: The  total number  of cells  was  signiﬁcantly  reduced,  while  the  proportion  of  neurons  was  greatly
increased  by AraC-treatment.  Cell  type-speciﬁc  labeling  demonstrated  that  nearly  all  ﬁbroblasts  and
most  of  the  glial  cells  were  removed.  Neither  the  neuronal  survival,  nor  the  neurite  outgrowth  or  soma
diameter  were  negatively  affected.  Additionally  neurites  remain  partly free  of  surrounding  non-neuronal
cells.
Comparison  with  existing  method:  Recent  culture  conditions  allow  only  for short-term  cultivation  of neona-
tal SGC  and  lack  information  on  the inﬂuence  of non-neuronal  cells  on  SGN  and  of direct  contact  of  neurites
with  test-materials.
Conclusions:  AraC-addition  reduces  the  number  of  non-neuronal  cells and increases  the  ratio  of  SGN  in
culture,  without  negative  impact  on  neuronal  viability.  This  treatment  allows  longer-term  cultivation
of  SGC  and  provides  deeper  insight  into  SGN-glial  cell  interaction  and  the attachment  of  neurites  on
test-material  surfaces.
©  2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
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165-0270/© 2016 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. IntroductionAbout 5% of the world’s population, over 360 million peo-
ple, are affected by disabling hearing loss (WHO, 2015). Most
of these patients suffer from sensorineural hearing loss that is
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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haracterized by irreversible damage of the sensory epithelium
hair cells) and partial degeneration of the auditory nerve, involv-
ng the spiral ganglion neurons (SGN). To date, cochlear implants
CIs) are the sole option for restoring hearing in patients affected
y sensorineural hearing loss or deafness. The intracochlear elec-
rode array of the CI enables the electrical stimulation of the SGN.
rogressive development of the CI in recent years by means of
echnical innovations such as novel speech-processing strategies
as improved the beneﬁts of these implants for patients. Today,
herefore, most implanted patients obtain open speech recogni-
ion (Battmer et al., 1999). However, technical improvements are
imited by anatomical conditions in patients, which inﬂuence the
mportant nerve–electrode interface. Further improvements to the
I outcome for patients with long-time deafness are, inter alia,
ffected by retraction of peripheral nerve ﬁbers after hair cell loss
nd subsequent degeneration of the SGN. This neuronal degen-
ration occurs much more slowly in humans than in animals
Altschuler et al., 1999; Gillespie and Shepherd 2005; Glueckert
t al., 2005; Alam et al., 2007; Liu et al., 2015). However, the
reservation and regeneration of the SGN and their nerve ﬁbers are
ssumed to be important aspects for further implant improvement.
Previous in vivo studies have detected the potential of simul-
aneous electrical stimulation and neurotrophic factor (NTF)
reatment to increase SGN survival (Lousteau 1987; Hartshorn
t al., 1991; Leake et al., 1991, 1999, 2011; Mitchell et al., 1997;
hinohara et al., 2002; Yamagata et al., 2004; Roehm and Hansen
005; Scheper et al., 2009; Shibata et al., 2010). Additionally, neu-
ite outgrowth of the peripheral spiral ganglion ﬁbers from the
odiolus into the scala tympani is reported (Wise et al., 2005, 2010;
lueckert et al., 2008; Shibata et al., 2010; Landry et al., 2013). These
n vivo studies are based on cell culture experiments. Explanted pri-
ary spiral ganglion cells (SGCs), including the auditory neurons,
re a well-established model for exploring their biological response
o new therapy strategies for CI improvement. The composition of
he cultured cells is inﬂuenced by the anatomical conditions of the
nner ear. The cell bodies of the bipolar SGN are situated within
osenthal’s canal in the cochlea. Peripheral processes, the den-
rites, project from the soma of the SGN through the osseous spiral
amina to the hair cells in the organ of Corti. Together, the central
rocesses – the axons – form the auditory nerve, which terminates
n the cochlear nucleus of the brain. Two types of SGN can be dis-
inguished on the basis of factors including their morphology and
eripheral target. The large type I SGN project to the inner hair cells
 these account for 90–95% of the SGN population – whereas the
emaining 5–10% are type II SGN that have a small cell body and
onnect to the outer hair cells (Spoendlin 1985; Rosbe et al., 1996;
ayagam et al., 2011; Green et al., 2012; Locher et al., 2014). The
erikaryons of the type I and type II SGN are enveloped by satellite
lial cells. Myelination of the neuronal cell bodies by this type of
lial cell differs between mammalian species. For example, the neu-
onal somata in the human cochlea are unmyelinated, whereas rat
GN cell bodies are surrounded by thin myelin (Rosenbluth 1962;
omand and Romand 1990; Toesca 1996; Hibino et al., 1999; Liu
t al., 2012; Locher et al., 2014). In contrast to unmyelinated SGN
ype II nerve ﬁbers, the ﬁbers of type I SGN are sheathed with typ-
cal compact myelin, produced by the associated spiral ganglion
chwann cells (SGSCs) (Rosenbluth 1962; Toesca 1996; Wang et al.,
009), in order to insulate individual ganglion neurons from neigh-
oring neurons and thus prevent electrical interference (Hibino
t al., 1999). SGSCs and satellite glial cells are located in the osseous
piral lamina, Rosenthal’s canal and the modiolus (Hurley et al.,
007; Jeon et al., 2011). Myelination with peripheral myelin synthe-
ized by SGSCs extends from the ﬁrst node of Ranvier peripherally
o the habenula perforata, bordering the organ of Corti, where the
endrites continue unmyelinated.ce Methods 268 (2016) 106–116 107
Therefore, the primary cultures derived from cells of Rosen-
thal’s canal contain not only SGNs but also the above-mentioned
non-neuronal cells, SGSCs and satellite glial cells (positive for S100
immunolabeling). The ratio of SGSCs and satellite glial cells to SGNs
varies widely, between 1:1 (Vieira et al., 2007), 12:1 (Mattotti et al.,
2015) and about 7500:1 (30,000:4) (Hansen et al., 2001). A small
proportion of non-neuronal cells in the SGC culture is accounted
for ﬁbroblasts (3%; immunolabeled by vimentin), astrocytes (2%;
GFAP-positive) and oligodendrocytes (<0.5%; RIP-positive (Hansen
et al., 2001; Furze et al., 2008; Jeon et al., 2011)).
Glial cells play an important role in neuronal development, sur-
vival, regeneration and axonal guidance both in vivo and in vitro.
This involves their expressing trophic factors such as brain-derived
neurotrophic factor (BDNF), neurotrophin 3 (NT3) and ciliary neu-
rotrophic factor (CNTF), and their elaborating extracellular matrix
and cell surface proteins for neurite promotion, such as laminin-1,
which induces the close association of the neurons and glial cells
(Bunge, 1994; Aletsee et al., 2001; Hansen et al., 2001; Boström
et al., 2007; Vieira et al., 2007; Whitlon et al., 2009; Clarke et al.,
2011; Jeon et al., 2011; Green et al., 2012; He et al., 2014; Sun et al.,
2014; Mattotti et al., 2015).
In dissociated cell culture in vitro, there is a notable increase
of the non-neuronal cell number detectable (Hansen et al., 2001;
Boström et al., 2007; Whitlon et al., 2009), whereas proliferation
due to reentry into the cell cycle of glial cells after deafening is
considerably limited in vivo (Provenzano et al., 2011). This prolif-
eration of the non-neuronal cells, especially of neonatal cells, leads
to difﬁculties with long-term cultivation due to overgrowth of the
SGN. A more severe problem is that the inevitable presence of other
cell types than the SGN introduces an uncontrolled variable in cell
culture experiments. Therefore, the effect of treatment strategies
– such as surface coatings/structures or exogenous growth factor
application on neuronal survival rate or neurite outgrowth and
guidance in culture – could be mediated or augmented by the secre-
tion of endogenous factors or molecules from the non-neuronal
cells (Staecker et al., 1995; Marzella et al., 1997, 1999; Aletsee et al.,
2001; Vieira et al., 2007; Whitlon et al., 2009).
Addition of the mitotic inhibitor cytarabine (AraC), a selective
DNA synthesis inhibitor, is an established method of inhibiting
ﬁbroblast and glial cell proliferation in neuronal cultures, lead-
ing to puriﬁcation of the Schwann cells and/or neurons (Brockes
et al., 1979; Mao  and Wang 2001; Negishi et al., 2003; Pettingill
et al., 2008; Xiao et al., 2010; Jeon et al., 2011; Provenzano et al.,
2011).
The intention of the present study was  to establish a neuron-
enhanced dissociated SGC culture of neonatal rats cultured for up to
seven days, while inhibiting the proliferation of the non-neuronal
cells by AraC. Dissociated neonatal SGC-cultures for testing of
treatment strategies are commonly performed for two to ﬁve
days. Therefore the cultured cells were analyzed after four days
and the cultivation time of the neonatal cells was prolonged to
one week. For a general maintenance of cells, serum (FCS) was
added to the culture medium. Compared to that the neurotrophins
BDNF and NT3 were chosen as additives for a speciﬁc neuronal
support and to test these deﬁned and well investigated growth
factors in the mitotic inhibited SGC-culture. An additional rea-
son to investigate BDNF and NT3 was  that they are produced
in vitro by the spiral ganglion Schwann cells. Since the Schwann
cells were potentially reduced by mitotic inhibition, we  aimed
to mimic  the production of these NTFs. To estimate the inﬂu-
ence of mitotic inhibition, cell composition, neuronal viability and
appearance in culture with and without mitotic inhibition were
analyzed in order to consider suitability for in vitro testing in audi-
tory research.
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. Materials and methods
.1. Spiral ganglion cell preparation and dissociation
All experiments were performed in accordance with the Ger-
an ‘Law on Protecting Animals’ and with the European Directive
010/63/EU for protection of animals used for experimental pur-
oses and registered (no. 2013/44) with the local authorities of
he Hannover Medical School and reported on a regular basis as
emanded by law (§  4). Early postnatal (P2-4) Sprague Dawley rats
f both sexes were dissected for primary cell harvesting for in vitro
ulture. The detailed preparation procedures have been published
reviously (Schwieger et al., 2015). Brieﬂy, the rats were rapidly
ecapitated, the skull was opened, the brain removed and the tem-
oral bones transferred into a Petri dish (60 × 15 mm;  BD Falcon)
lled with ice-cold Ca2+-/Mg2+-free d-phosphate-buffered saline
PBS; Invitrogen). Next, the membranous cochleae were dissected
ut of the temporal bones, followed by separation of the spiral gan-
lia and transfer to ice-cold Ca2+-/Mg2+-free Hank’s balanced salt
olution (HBSS; Gibco Invitrogen).
Readers are referred to previous descriptions of enzymatical
nd mechanical dissociation of the SGC (Wefstaedt et al., 2005;
chwieger et al., 2015). Spiral ganglia were pooled and digested
n HBSS containing 0.1% trypsin (Biochrom) and 0.01% DNase I
Roche; 30–40 ganglions/2 ml). After 16 min  of incubation at 37 ◦C,
rypsinization was stopped by withdrawal of the supernatant and
ddition of fetal calf serum (FCS; Invitrogen). FCS, trypsin and DNase
ere washed out with serum-free culture medium (see below) and
he SGC were mechanically dissociated with a 1.000 l pipette tip
ollowed by a 200 l pipette tip (TipOne, StarLab) in 1 ml  of the
erum-free medium. Trituration was repeated until no cell clusters
ere visible in the SGC suspension. Afterwards the cell number was
ounted using the trypan blue (Sigma–Aldrich) exclusion test in a
eubauer chamber (BRAND GmbH). Finally, cells were seeded at
 density of 1.4 × 104 cells/well in a previously poly-dl-ornithine-
0.1 mg/ml; Sigma–Aldrich)/laminin-(0.01 mg/ml; Naturel Mouse
aminin; Invitrogen) coated 96-multiwell culture plate (Nunc A/S).
.2. Cultivation of spiral ganglion cells
For all performed analyses of neurons and non-neuronal cells
nder various treatment conditions, cells were cultured in 96-
ell plates for four and seven days in a medium consisting of
anserin 401 (PAN Biotech) supplemented with 1 M HEPES buffer
olution (Invitrogen), PBS, penicillin (30 U/ml; Biochrom), glucose
40%/ml; B. Braun), insulin (4 mg/ml; Biochrom) and N-2 supple-
ent (Invitrogen) in an incubator (CB 150 E3; Binder) at 37 ◦C,
% CO2 and humidity of 95%. Depending on the experimental
etup, the serum-free medium was conditioned with 10% FCS
r 50 ng/ml BDNF (Invitrogen) with and without 50 ng/ml NT3
antibodies-online GmbH), and with or without 1.4 g/ml (5 M)
raC (Sigma–Aldrich). Medium was changed every 2–3 days. For
ell type-speciﬁc staining, SGCs were seeded on poly-dl-ornithine-
nd laminin-coated glass coverslips, and cultured for four and seven
ays with BDNF and NT3, and with or without AraC. After the
ppropriate incubation periods, cells were ﬁxed either with a 1:1
cetone (J.T. Baker)/methanol (Roth) solution for neuronal label-
ng or with a 4% paraformaldehyde (PFA, Merck Millipore) solution
or cell type-speciﬁc labeling for 10 min  at room temperature. Cells
ere subsequently washed three times using PBS and stored in PBS
t 4 ◦C..3. Total cell count
To obtain the total cell number per well, SGC were culti-
ated in 96-well plates and, for each experimental condition, threece Methods 268 (2016) 106–116
independent experiments carried out in triplicate were analyzed.
All cells were detached from the well by trypsinization, and the cell
number was  counted with a Neubauer chamber using the trypan
blue exclusion test. Firstly, culture medium was  carefully removed
and possible residues of medium were washed out using Hank’s Salt
Solution (Biochrom). Subsequently, 100 l/well of trypsin (0.25%)
were added to the cells and incubated for 5 min  at 37 ◦C. After incu-
bation, the detachment of the cells was  microscopically monitored
and trypsinization stopped by adding 200 l of medium containing
10% FCS. Cells were then resuspended by pipette, and the cell count
was performed under inverted light microscope (Olympus CKX 41).
If the cells were incompletely resuspended or no cell was counted
during the ﬁrst test, it was repeated and the results were averaged.
This method for total cell count was applied to avoid additional
washing steps and loss of cells by ICC (see Section 3).
2.4. Immunocytochemistry
For analysis of neuronal survival, neurite outgrowth and soma
diameter, neurons in culture were labeled speciﬁcally for the
200 kD neuroﬁlament. A detailed protocol has been described pre-
viously (Wefstaedt et al., 2005). Brieﬂy summarized, the primary
antibody utilized was a monoclonal mouse 200 kD neuroﬁlament
(Novocastra) antibody, with subsequent use of the Vectastain®
Elite® ABC kit (Vector Laboratories) and with a peroxidase substrate
kit (DAB; Vector Laboratories) employed for visualization.
As the aim was  to investigate the inﬂuence of AraC on the cell
population in SGC culture, additional immunocytochemical stain-
ing for neurons (neuroﬁlament) and non-neuronal cells (S100: glial
cells, vimentin: ﬁbroblasts) was  carried out (Hibino et al., 1999;
Hansen et al., 2001; Hurley et al., 2007; Clarke et al., 2011; Jeon
et al., 2011; Anacker et al., 2013). Cells were permeabilized with
PBS containing 0.25% Triton X-100 (Sigma–Aldrich) (PBT) and then
blocked using PBS containing 5% FCS and 0.1% Triton X-100. Primary
and following secondary antibodies were then added. The neurons
were stained against the 200 kD neuroﬁlament, while ﬁbroblasts
were labeled with an antibody against vimentin and the glial cells
for S100 (Table 1). Finally ProLong® Gold antifade reagent with
DAPI (Invitrogen) was  used for preservation and nucleus labeling.
Images were taken with an inverse ﬂuorescence microscope (Olym-
pus BX51, Olympus Life Science) connected to an Olympus XM10
camera (Olympus Life Science), using cellSens software (Olympus
Life Science).
2.5. Neuron analysis
To evaluate the impact of AraC on neuronal viability, three inde-
pendent experiments – carried out in triplicate for each condition –
were analyzed for the number of surviving neurons per well, neu-
rite length and soma diameter. In order to determine the effect
of the mitotic inhibitor on cell type distribution, the number of
neurons as a percentage of the total cell number per well was  cal-
culated. Therefore, the total cell number per well, known from the
total cell count experiments (Section 2.3), was  taken as 100% and
the number of counted neurons was set as a percentage of this 100%
total cell amount. The number of non-neuronal cells per neuron in
the total cell population was calculated, the detected number of
surviving neurons per well was  then subtracted from the total cell
number per well to obtain the proportion of non-neuronal cells,
which was ﬁnally related to one neuron. Neuron analysis and image
taking were conducted using an inverted microscope (Olympus
CKX 41) combined with a CCD-camera (Colorview XS, SIS).Cells labeled positive for neuroﬁlament, having neurites with a
length of at least three times that of the soma diameter, were rated
as being surviving neurons (Gillespie et al., 2001) and counted for
the different experimental conditions and periods of incubation.
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Table  1
Cell-speciﬁc antibodies.
Antibody Antigen Host, type, dilution Company, cat. no.
Primary antibodies
Anti-200 kD Neuroﬁlament heavy antibody 200 kD neuroﬁlament Chicken, polyclonal, 1:10,000 Abcam, ab4680
Monoclonal mouse anti-vimentin clone V9 Vimentin Mouse, monoclonal, 1:100 DakoCytomation, M0725
Anti-S100 antibody-astrocyte marker S100 isoforms Rabbit, polyclonal, 1:75 Abcam, ab868
Secondary antibodies
® Goat, polyclonal, 1:250 Abcam, ab96947
Goat, polyclonal, 1:250 Abcam, ab97037
Goat, 1:500 Jackson ImmunoResearch, 111-165-045
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Fig. 1. Detachment of cells.
When SGC were cultivated with 10% FCS and without AraC addition (especially after
seven days), the cell layer grew so thick in places that it became locally detached
(→)  from the plate. No detachment of cells was  observed in the NTF-treated or AraC-
treated conditions. SGC underwent neuron-speciﬁc staining for neuroﬁlament with
DAB. Magniﬁcation: 40×.
Fig. 2. Total cell number per well.
Effect of AraC (1.4 g/ml) and different factors (10% FCS, 50 ng/ml BDNF and 50 ng/ml
BDNF + 50 ng/ml NT3) on the total cell number per well after four and seven days
in  vitro. Each condition with AraC is plotted and compared against the same condi-
tion without the inhibitor. The statistically signiﬁcant differences are plotted above
the  relevant AraC bar (i.e., the dotted bars). After four days of culture, the highest
cell population was measured in FCS-conditioned SGC culture. The detected signif-
icances for the 4d FCS-treatment are marked on the lower line referring to the FCS
4d  bar. With AraC, the cell number decreased signiﬁcantly (FCS + AraC 4d; p < 0.01).
After seven days, all treatment groups with AraC had signiﬁcantly lower cell countsGoat anti-chicken IgY (H + L) DyLight 488 Chicken IgY H&L 
Goat  anti-mouse IgG H + L (Cy5®) Mouse IgG H&L 
CyTM3-conjugated AfﬁniPure goat anti-rabbit IgG (H + L) Rabbit IgG H&L
he neurite length of the SGNs was analyzed based on images taken
rom at least ﬁve ﬁelds of view per well (Gillespie et al., 2001).
sing an image analysis program (CellP, SIS, Olympus), measure-
ents were taken of the neurite outgrowth and soma diameter of
0 randomly selected neurons with the longest clearly traceable
eurites per well (two per each ﬁeld of view) (Gillespie et al., 2001;
erkingali et al., 2008; Kaiser et al., 2013). Neurons with neurites
ouching the side of the well or overlapping with other neurites
ere excluded from the analysis (Vieira et al., 2007). Measurement
as followed by statistical analysis.
.6. Statistical analysis
Data were analyzed as mean ± standard error of the mean (SEM)
or statistical signiﬁcance. The tests applied were the repeated-
easures one-way analysis of variance (ANOVA) followed by
onferroni’s Multiple Comparison test using GraphPad Prism® soft-
are. Statistical signiﬁcance was considered at p values less than
.05.
. Results
The results presented focus on the direct comparison of
he AraC-treated and AraC-untreated groups, and highlight the
ost interesting instances of signiﬁcance in the text. For all
uch instances found, we refer to the Supplementary material,
ables S1–S5. Furthermore, for clarity’s sake, only the relevant
eans ± SEM are presented in the text. All means ± SEM are sum-
arized in Table 2.
.1. Total cell count
By counting all surviving cells per well, the effect of mitotic inhi-
ition by AraC on all cells of the SGC culture was  detected. In the
AB-stained culture wells, detachment of the overgrowing cell lay-
rs (Fig. 1) was noticed in some cases when no AraC was added
n the FCS conditions. In the unstained cultures, two wells with
CS-only-treatment showed after change of medium on the fourth
ay a loss of about 10% of the cell layer. This has led to some cell
oss during cultivation, which decreased the number of counted
ells and inﬂuenced the variability of the results for the uninhibited
CS-culture condition.
The addition of AraC resulted in a reduction of cells in all condi-
ions (FCS, BDNF, BDNF + NT3; four–seven days; Fig. 2). After four
ays of cultivation, a signiﬁcant reduction of the total cell num-
er was detectable by addition of FCS and AraC compared to FCS
ithout AraC (p < 0.01), but not for the NTF-treated groups. After
even days of incubation, AraC had a highly signiﬁcant cell-reducing
ffect in all conditions (FCS: p < 0.001; BDNF: p < 0.01, BDNF + NT3: < 0.01). While the number of cells increased over time in all condi-
ions without AraC, it decreased with longer incubation with AraC.
he highest number of cells for the two analyzed time points was
ounted, when FCS was added without AraC, after four days (sig-
than without AraC. At this time point and with the addition of FCS, the number of
cells was higher – and signiﬁcantly so – than all other conditions. These signiﬁcances
are plotted on the upper line referring to the FCS 7d bar (mean ± SEM; **p  < 0.01;
***p  < 0.001; ns = not signiﬁcant; independent experiments = 3, wells = 3)
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Table  2
Mean ± SEM of all evaluated data.
FCS + AraC FCS BDNF + AraC BDNF BDNF + NT3 + AraC BDNF + NT3
Total cell count in cells/well
4d Mean 1725 15,950 2325 9550 2050 8575
SEM  183.7 2075 375 1073 383.2 1171
7d Mean  950 29,450 700 15,025 625 14,950
SEM  175 3521 165.4 2484 134 1250
Neuronal survival in neurons/well
4d Mean 51.22 124.9 96.11 100 186.1 172.2
SEM  7.08 23.98 5.55 33.73 17.15 37.72
7d Mean  76.78 46.78 76.89 60.11 101 135.6
SEM  15.39 12.61 7.85 5.39 13.7 17.72
Percentage of neurons in %
4d  Mean 3 0.81 4.13 1.31 9.29 2.08
SEM  0.32 0.07 0.25 0.73 1.55 0.37
7d Mean  8.6 0.17 12.65 0.45 16.31 0.89
SEM  2.32 0.06 4.39 0.12 1.76 0.1
Non-neuronal cells per one neuron
4d Mean 33.07 123.6 23.42 129.8 10.5 49.99
SEM  3.30 10.27 1.56 51.79 2.23 8.52
7d  Mean 13.23 1173 8.64 270.4 5.295 114.1
SEM  4.918 738.8 2.52 89.19 0.76 11.81
Neurite length in m
4d Mean 513.3 788.7 776.4 855.7 921.6 871.2
SEM  22.02 31.22 23.59 24.42 19.73 20.01
7d  Mean 896.6 959.9 1118 1265 1030 1197
SEM  30.18 37.75 36.94 35.09 27.79 29.66
Soma  diameter in m
4d  Mean 14.77 16.1 15.78 15.59 16.15 15.79
5 0.35 0.33 0.32
.88 18.16 17.39 18.64
9 0.32 0.27 0.34
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Fig. 3. Neuronal survival.
Different conditions (10% FCS, 50 ng/ml BDNF and 50 ng/ml BDNF + 50 ng/ml NT3)
of  SGC culture were analyzed for the number of surviving neurons per well (with
addition and withdrawal of the mitotic inhibitor AraC (1.4 g/ml) after four and
seven days of in vitro cultivation). There was no signiﬁcant (ns) negative effect of
AraC  on the number of neurons detectable for the various conditions compared, as
indicated above the relevant AraC treatment bars. The highest number of neurons
was  counted after four days of cultivation with BDNF, NT3 and AraC, with signiﬁcant
differences compared to both FCS conditions (with and without AraC) after four and
seven days, and differences to the BDNF with and without AraC-treated cells after
seven days (signiﬁcances plotted on the line, referring to the BDNF + NT3 + AraC 4d
bar). One general observation was the tendency for neuron number to decrease over
time. Differences for the conditions with and without mitotic inhibitor addition
are marked above the AraC error bars (mean ± SEM; *p < 0.05; **p < 0.01; ns = notSEM  0.31 0.38 0.3
7d  Mean 17.48 17.23 16
SEM  0.33 0.39 0.2
iﬁcant difference compared to all AraC-treated groups; p < 0.01)
nd after seven days (signiﬁcant difference compared with all other
roups; p < 0.01 and p < 0.001; Fig. 2).
.2. Neuronal survival
The number of surviving neurons per well was counted for each
ondition. In the FCS-treated, AraC-untreated wells, local detach-
ent of the ﬁrst cell layer (Fig. 1) in the four day cultures was
bserved. Except for one well with about 30% of detachment, the
rea of detachment was approximately under 5%. The detachment
as mainly limited to the non-neuronal cells, except after seven
ays of cultivation. Here the overgrowing non-neuronal cell layers
ere extensively washed away. In three wells 10–30% and in two
ells 2–5% of the SGN-containing undermost layer was  detached.
his may  have resulted in local loss of single neurons for the serum
ontaining, AraC-untreated conditions, and these detached areas
ere excluded from analysis.
AraC did not reduce the number of neurons when compared
ith the relevant AraC-untreated controls. Overall, this num-
er tended to decrease over time. The quantity of neurons was
ncreased by treatment with BDNF and NT3 after four and seven
ays of cultivation, with the best neuronal survival rates observed
fter four days of incubation with BDNF and NT3 supplemented
ith AraC. This number of neurons was signiﬁcantly higher than
hen using FCS with AraC after four days (p < 0.01), and FCS and
DNF with and without AraC after seven days of cultivation (p < 0.05
nd p < 0.01) (Fig. 3).
.3. Percentage of neurons
The total cell number per well was taken as 100%, and the num-
er of neurons in each case is given as a percentage of this total.
dding the mitotic inhibitor AraC resulted in an increased ratio of
eurons to non-neuronal cells. This increase was signiﬁcant for all
onditions analyzed after seven days in culture with AraC. Treat-
signiﬁcant; independent experiments = 3, wells = 3).
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Fig. 4. Percentage of neurons in culture.
The bar chart plots the effect on the percentage of SGN in the SGC culture of dif-
ferent factors (10% FCS, 50 ng/ml BDNF and 50 ng/ml BDNF + 50 ng/ml NT3), each
combined with 1.4 g/ml AraC for four and seven days in vitro. The proportion of
SGN  was  signiﬁcantly increased by the addition of AraC for all conditions after seven
days. Asterisks and ‘ns’ above the AraC error bars show the signiﬁcance of the AraC
conditions compared to the relevant negative control without AraC. The combi-
nation of BDNF and NT3 with AraC on cultured cells for seven days resulted in
the highest percentage of neurons per well – and by a signiﬁcant margin – com-
pared to most of the other conditions (see line with asterisks corresponding to the
BDNF + NT3 + AraC 7d bar) (mean ± SEM; *p < 0.05; ***p < 0.001; ns = not signiﬁcant;
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Fig. 5. Non-neuronal cells per neuron.
The bar chat plots the number of non-neuronal cells per SGN  in the SGC culture under
different culture conditions (10% FCS, 50 ng/ml BDNF and 50 ng/ml BDNF + 50 ng/ml
NT3, each with and without 1.4 g/ml AraC) after four and seven days of cultivation.
measured after treatment of the SGC with FCS and AraC for
four days (513.3 ± 22.02 m),  with signiﬁcant differences com-ndependent experiments = 3, wells = 3)
ent with BDNF, NT3 and AraC for seven days resulted in the
ighest neuronal fraction, with a signiﬁcant margin for all AraC-
ntreated conditions (p < 0.001). Additionally, 7 day treatment with
DNF, NT3 and AraC signiﬁcantly increased the percentage of
eurons compared to four days cultivation of serum + AraC and
DNF + AraC. With this treatment, the proportion of SGNs achieved
as about 16% (16.31 ± 1.76%; Fig. 4).
.4. Number of non-neuronal cells per neuron
The number of non-neuronal cells per neuron was calculated
y deducting the detected number of surviving neurons per well
rom the total cell number per well, which was then related
o one neuron. This number increased over time when mitosis
as not inhibited. When FCS without AraC was added to the
ells for four days, the quantity of non-neuronal cells per neuron
as 123.6 ± 10.27. One week of cultivation with FCS and with-
ut AraC resulted in an almost 10-fold higher cell-neuron ratio
ith 1173 ± 738.8 cells per neuron. With NTF treatment, the num-
er of non-neuronal cells after seven days (114.1 ± 11.81) only
pproximately doubled compared to the cell number after four
ays (49.99 ± 8.52) of incubation. AraC treatment resulted after
even days in about half of the number of non-neuronal cells com-
ared with four-day culture (Table 2). No statistical differences
ere detected between groups (Fig. 5).There is a noticeable tendency for the number of non-neuronal cells per neuron to
decrease where AraC is added, and for this number to increase over time without
mitotic inhibition. Data are presented as mean ± SEM.
3.5. Different cell types
Using immunocytochemistry for 200 kD neuroﬁlament (NF),
vimentin and S100, three different cell types were detected in
the SGC culture after seven days of incubation (Fig. 6). Next to
the NF-positive SGN population there was  the population of non-
neuronal cells, in the main vimentin-positive and S100-positive,
with bipolar morphology, being spindle-shaped, and hence glial
cells. A smaller proportion of the non-neuronal cells was labeled
positive for vimentin but negative for S100, and exhibited a
broad-based stellate morphology typical of ﬁbroblasts. Very few
cells were labeled for DAPI and none of the cell type-speciﬁc
antibodies. Without addition of the mitotic inhibitor AraC, the non-
neuronal cells formed a monolayer, with the neurons integrated
(Fig. 6A). When the ratio of non-neuronal cells was decreased
by AraC-mediated inhibition of cell division, nearly all ﬁbroblasts
and a large proportion of the glial cells were eliminated (Fig. 6B).
As indicated in Fig. 6B, glial cells chieﬂy remain neuron-/neurite-
associated in the culture after AraC treatment.
3.6. Neurite outgrowth and soma diameter
Neurite outgrowth in terms of neurite length and soma diam-
eter was measured as an indicator of neuronal health after AraC
substitution. No negative effects of AraC on neurite outgrowth
(Fig. 7A) and soma diameter (Fig. 7B) were detected when com-
pared with the AraC-free controls. The shortest neurites werepared to all other conditions (p < 0.05–p < 0.001), except for four
days’ treatment with FCS only or BDNF with AraC. Where cells
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Fig. 6. Cell types in culture.
After seven days of cultivation with normal cell division, most non-neuronal cells
were labeled positive for S100 (glial cells, yellow; A). A marked reduction of
vimentin-positive cells (ﬁbroblasts, red) and, in particular, S100-labeled cells, is
observable where mitosis is inhibited for seven days (B). The remaining non-
neuronal cells were mainly located close to the SGN (neuroﬁlament-positive, green).
Cell nuclei and cell debris were labeled by DAPI (blue). SGN somata are marked by
asterisk, small arrows point on single ﬁbroblasts and thick arrows indicate ﬁbroblast
clusters. Magniﬁcation 100×.
Fig. 7. Neurite outgrowth and soma diameter.
Neurite length (A) and soma diameter (B), measured in m,  were analyzed for the inﬂuenc
BDNF  and 50 ng/ml BDNF + 50 ng/ml NT3) for four and seven day SGC culture. Neither ne
AraC  was  added. The shortest neurites were measured after four days of incubation with 
FCS  + AraC 4d bar in A). And the longest neurites were measured after seven days of incub
are  plotted on the upper line (A). The smallest soma diameters were observed after treat
to  some seven day treatment groups (plotted on the lower line in B). After seven days of 
asterisk on the upper line in B) largest soma were observed. The absence of signiﬁcant di
withdrawal is indicated above the AraC error bars (mean ± SEM; *p < 0.05; **p < 0.01; ***pce Methods 268 (2016) 106–116
were treated with only BDNF for seven days, the longest neu-
rites were regenerated (1260 ± 35.09 m)  signiﬁcantly compared
to all four-day conditions and FCS with AraC for seven days
(p < 0.05–p < 0.001). Comparing the various treatment groups at
both four and seven days, a signiﬁcant increase in neurite length
over time was  detected for FCS with AraC, BDNF with and with-
out AraC, and BDNF + NT3 without AraC addition (Supplementary
material) (p < 0.05–p < 0.001).
The soma diameter of four-day-cultivated SGN did not differ
between treatment conditions. Compared with cells cultivated for
seven days, those treated with FCS + AraC for four days were signiﬁ-
cantly reduced compared to neurons treated with FCS + AraC, BDNF,
BDNF + NT3 and BDNF + NT3 + AraC (Fig. 7B; p < 0.05–p < 0.001).
The largest soma diameter was  measured after treatment with
BDNF + NT3 for seven days (18.61 ± 0.34 m),  i.e.,  a signiﬁcant
increase compared to BDNF + AraC, BDNF and BDNF + NT3 after four
days of treatment (p < 0.05–p < 0.01). A signiﬁcant increase in soma
diameter over time (four to seven days) was detected for FCS with
AraC and BDNF without AraC (Supplementary material) (p < 0.05)
(Fig. 7B).
With AraC-addition, the neurites remain partly free of surround-
ing non-neuronal cells with a direct contact to the surface of the
culture plate. And there was  one additional ﬁnding that was both
interesting and unexpected. During measurement of neurite length,
phenomena were observed that had not been seen before under
standard culture conditions: namely, morphological changes with
increased branching and a tendency among the neurites of the SGN
(Fig. 8) towards fasciculation and connection following a strong
reduction in the amount of non-neuronal cells. This effect was  most
conspicuous after seven days of incubation with BDNF + NT3 and
cell growth inhibition, which also correlated to the highest neuron
density of all conditions (see above).
4. Discussion
SGC culture is a widely used method in basic auditory research.
This culture contains neurons, ﬁbroblasts and glial cells. Due to
cell division of the non-neuronal cells, especially of neonatal SGC,
and known apoptosis of neurons over time of cultivation, the bal-
ance between neuronal and non-neuronal cells is impaired and
e of 1.4 g/ml mitotic inhibitor AraC with different factors added (10% FCS, 50 ng/ml
urite outgrowth nor soma diameter differed signiﬁcantly in each condition when
FCS and AraC (in some cases signiﬁcantly, plotted on the lower line referring to the
ation with BDNF and without AraC. Signiﬁcances compared to BDNF 7d-treatment
ment with FCS and AraC for four days, which were signiﬁcantly smaller compared
cultivation with BDNF + NT3 but without AraC, the (in some cases signiﬁcantly, see
fferences between the conditions in respect of mitotic inhibitor (AraC) addition or
 < 0.001; ns = not signiﬁcant; independent experiments = 3, wells = 3).
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Fig. 8. Representative images of SGN culture.
The SGN culture showed differences in neurite outgrowth when the mitotic inhibitor (B and D) was added, compared to native culture without AraC (A and C). The neurites are
partly  free of surrounding non-neuronal cells and appeared more branched, often connected to each other and fasciculate. This effect was most noticeable after seven days of
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or  neuroﬁlament with DAB. The glial cells are also visible, with a large amount in 
ext  to the neurites (D→).  Magniﬁcation: 40× (A and B), 200× (C and D).
ong-term in vitro studies being performed on these neurons are
indered. Reducing the seeding density to avoid overgrowth and
etachment is not an option, as this would also reduce the num-
er of neurons available for examination such that no differences
etween treatment and control would be detectable anymore.
urthermore, proliferating non-neuronal cells may  inﬂuence the
valuation of strategies to treat SGN.
This study is the ﬁrst to report a protocol for long-term culti-
ation of neonatal primary auditory neurons with a reduced glial
roportion by using the mitotic inhibitor AraC. The addition of AraC
educes the proliferation of non-neuronal cells without affecting
he viability of the SGN. Although a neurotoxic effect of AraC in vitro
s reported (Wallace and Johnson, 1989; Courtney and Coffey, 1999;
eeds et al., 2005; Delivopoulos and Murray 2011) AraC did not
ead to a decrease in neuronal survival rate, neurite length or soma
iameter compared to AraC-untreated neurons in the here pre-
ented study. The hypothetical negative effect of AraC on SGN was
lso possibly avoided by the used low dose of 1.4 g/ml (5 M)  of
raC. For example a concentration of 10 M AraC in vitro is indi-
ated as a non-toxic dose for cerebellar granule neurons (Courtney
nd Coffey, 1999; Leeds et al., 2005). The reduced trophic sup-
ort due to lower numbers of non-neuronal cells had no effect
n the SGN in this study. The known survival rate-enhancing and
eurite length-enhancing effects of BDNF and NT3 application
Lefebvre et al., 1994; Hegarty et al., 1997; Mou  et al., 1997;
algrange et al., 1998; Warnecke et al., 2007; Green et al., 2012;
ie et al., 2013) were not decreased by the reduced number of
on-neuronal cells resulting from AraC treatment. This justiﬁes the
ssumption that the beneﬁcial inﬂuence of BDNF and NT3 is a direct
ffect on the neurons and not mediated by the proliferating non-
euronal cells. Adding growth factors in addition to AraC treatment
reatly increased the proportion of neurons in the primary SGC cul-pared to cultivation without inhibition (A and C). SGN were labeled neuron-speciﬁc
 culture (C→)  and few cells in AraC-treated ones, where the glial cells are located
ture from below 1% after four days’ cultivation with only serum to
over 16% after one week with the NTFs. Moreover, the number of
non-neuronal cells per neuron was massively decreased after seven
days from, for example, 1173:1 with FCS addition and without AraC,
to 5:1 with BDNF + NT3 + AraC.
Under the experimental conditions of this study without mitotic
inhibition, the total number of cells rose over time. The slightly
reduced number of SGN indicates that the increase in total num-
ber of cells was  due to proliferation of non-neuronal cells. This is
consistent with previous studies in which ﬁbroblasts and glial cells
proliferate in peripheral nerve culture but neurons do not (Brockes
et al., 1979; Hansen et al., 2001; Boström et al., 2007; Whitlon et al.,
2009). The most abundant non-neuronal cells detected in the cul-
ture used in the present study were cells that were S100-positive
and spindle-shaped and hence glial cells (SGSCs and satellite cells).
This is consistent with the ﬁndings of Hansen et al. (2001), namely
with >95% of the non-neuronal cells determined as S100-positive
SGSCs, and those of Mattotti et al. (2015), with S100-positive cells
accounting for about 60%. Without AraC, the distribution of non-
neuronal cells in the well was diffuse (Figs. 6 A and 8 A and C).
After AraC treatment, the glial cells were mainly neuron-associated,
and vimentin-positive cells with ﬁbroblastic morphology were
very rare (Figs. 6 B and 8 B and D). This might indicate that
neuron-associated glial cells proliferate more slowly and therefore
survive mitotic inhibition. Hansen et al. (2001) described FCS as
being a Schwann cell mitogen. This is conﬁrmed by the markedly
increased number of non-neuronal cells after incubation with FCS
in the experiments described here. Another possible explanation
for the glial-neuron association would be that the remaining SGSCs
migrate to the neurons to interact with them (Boström et al., 2007).
Very few cells in the analyzed culture were not labeled by the cell
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ype-speciﬁc antibodies (approximately 2%), which is in accordance
ith previous ﬁndings (Hansen et al., 2001; Jeon et al., 2011).
It is discussed in the literature that the results of experiments
nvestigating the effects of growth factors on, for instance, SGN
urvival rate and neurite outgrowth or guidance tested in vitro,
re inﬂuenced by uncontrolled proliferation of SGSCs (Staecker
t al., 1995; Marzella et al., 1997, 1999; Aletsee et al., 2001;
ieira et al., 2007). For example, Hansen et al. (2001) demon-
trated that BDNF and NT3 are expressed in dissociated cultured
GSCs. It is also demonstrated that, in vivo, the proliferation of
GSCs is limited after reentry into the cell cycle following deafening
Provenzano et al., 2011). Deafened animals exhibited signiﬁcantly
igher levels of SGSC proliferation, as proven by BrdU uptake,
han in normal-hearing animals, whereas the total number of SCs
emained stable. In the present study, the proliferation of non-
euronal cells was slower under NTF treatment (i.e., rapid with
CS), while the number of surviving neurons – and therefore the
euronal proportion – was increased. Thus, under mitotic inhibi-
ion using AraC, the ratio of neurons to non-neuronal cells increased
ver time, whereas the number of neurons in relation to that
f non-neuronal cells decreased over time without AraC. In the
resent study, the ratio of non-neuronal cells (mainly S100-positive
GSC and satellite cells) to neurons shows an extremely wide
ange from 5:1 (BDNF + NT3 + AraC after 7d) to 1173:1 (FCS after
d). Ratios described in the literature also vary, from 1:1 (Vieira
t al., 2007) and 12:1 (Mattotti et al., 2015) to 7500:1 (30,000:4)
Hansen et al., 2001). This might be related to the animals
hemselves (neonatal, adult, species), the cultivation time or the
edium used, as well as to addition or withdrawal of NTFs
nd/or serum. Vieira et al. (2007) cultivated adult mouse SGC
n neurobasal medium (+B-27 supplement) enriched with BDNF,
eukemia inhibitory factor (LIF) and NT3 for four days. Mattotti et al.
2015) investigated dissociated P5 rat SGCs for one to seven days
n the same medium, but with the addition of glial cell line-derived
eurotrophic factor (GDNF). Hansen et al. (2001) examined P5 rat
GC for four days (in the absence of NTFs) in DMEM to which N-
 supplement was added. Our ﬁnding most comparable to that of
hese experimental setups is the result for the cell-neuron ratio
fter four days with BDNF and NT3 with 50:1 non-neuronal cells
er neuron. In contrast to these other setups, in the present study
omplemented panserin was used as the basal medium (a standard
edium for NTF-treatment testing on SGC), NTF/serum was added
nd the SGCs were derived from P2-4 rats. These differences may
ccount for the reduced viability of SGN (Warnecke et al., 2007;
aiser et al., 2013). Jin et al. (2013) observed that the density of non-
euronal cells decreased with increasing age (P0–P20) of the donor
nimal. This might explain why dissociated SGC of mature animals
ould be maintained for several weeks (Rask-Andersen et al., 2005;
oström et al., 2007; Wei  et al., 2007), whereas we observed detach-
ent of cells after only one week as a function of additive use. With
 combined AraC- and NTF-treatment the ratio of non-neuronal
ells to neurons for our neonatal SGC-culture (5:1 after 7d) is more
imilar to the documented ratio of 1:1 (Vieira et al., 2007) for adult
GC-culture.
In the recent study with AraC addition, neurites partly free of
urrounding non-neuronal cells were observed. Additionally we
oticed changes in the neurite outgrowth with a tendency among
he neurites regenerated from the SGNs towards fasciculation and
onnection.
This was most prominent after seven days in culture under treat-
ent with both NTFs and the mitotic inhibitor. This effect was not,
owever, observed where glial proliferation was unaffected. The
educed number of SGSCs in AraC-treated conditions may  have
ed to the changes in the branching and course of the neurites.
hysiologically, Schwann cells are associated with the neurites of
he SGN. In situ, the neurites are unmyelinated peripherally to thece Methods 268 (2016) 106–116
habenula perforata (Hurley et al., 2007; Locher et al., 2014) due to
absence of SGSCs behind this anatomical barrier to the organ of
Corti, where they connect to the hair cells. Furthermore, regener-
ated nerve ﬁbers in the scala tympani (Roehm and Hansen 2005;
Wise et al., 2005, 2010; Shibata et al., 2010; Landry et al., 2013),
where the cochlear implant electrode array is situated, are not sur-
rounded by SGSCs, this being due to a lack of glial cells beyond the
osseous spiral lamina. In vitro, the associated SGSCs align the SGNs
and also guide the regenerated neurites (Boström et al., 2007, 2010;
Clarke et al., 2011; Khalifa et al., 2013). Other studies have demon-
strated that the non-neuronal cells form a monolayer in culture
that the SGN neurites use as a matrix to grow on, and on which they
avoid touching each other (Aletsee et al., 2001; Brors et al., 2002;
Boström et al., 2007; Furze et al., 2008). In vitro, there is no barrier
such as the habenula perforata to isolate the peripheral ending of
the dendrites from glial cells. In view of this, we hypothesize that
the observed formation of connected neurites might be caused by
the reduced number of glial cells and therefore a lack of guidance
and isolation.
Previous in vitro studies showing connection or network forma-
tion and synapse-like contacts between SGN were carried out on
adult cultured dissected inner ear neurons (Boström et al., 2007),
adult mouse SGN (Wei  et al., 2007) or adult human and guinea pig
neurosphere-derived SGN (Rask-Andersen et al., 2005) after long-
term cultivation. The morphological ﬁndings of these studies are
similar to the ﬁndings presented here. This may indicate that the
long-term cultivation of neonatal SGN with reduced proliferation
of glial cells by mitotic inhibition, and treatment of the neurons
with NTFs (such as BDNF and NT3), may  induce the formation of
neuronal connections similar to those of cultured adult SGN with
slowly proliferating glial cells. It is possible, that guidance of the
neurites by the SGSCs in AraC-untreated culture inhibits the con-
nections between neurons. The use of BDNF and NT3 might play
an important role in any connections, since both factors are known
to promote, inter alia, neuronal survival and neurite outgrowth, as
well as synaptogenesis and synaptic strength as reviewed by Green
et al. (2012).
With the technique presented in this study, the neurons can still
associate with SGSCs and satellite cells but uncontrolled prolifer-
ation of the glial cells is prevented. Furthermore, the neurites are
in some cases not surrounded by glial cells, which might enable
them to form connections. The AraC-inhibited glial cell prolifera-
tion and the (in part) SGSC-free SGN neurites could reﬂect a more
physiological organization of the SGC in vitro and therefore allow
new experimental setups for analysis (of connection) of regen-
erated neurites to target cells or an implant. This is particularly
interesting for tests of the interaction of neurites with surfaces. For
auditory research on regeneration and guidance of neurites from
auditory neurons to improve the CIs, this may  represent a consid-
erable beneﬁt. Longer-term observation of neonatal SGC in culture
is also possible, as is the detection of a more direct impact of treat-
ments on the neurons in vitro. It is also possible that the cultivation
procedure described could be used in more in-depth investiga-
tion (and therefore more detailed understanding) of SGN-glial cell
interaction.
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